These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7693945)

  • 21. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A; Fardin V; Cavero I
    Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist.
    Tousignant C; Chrétien L; Guillemette G; Regoli D
    Brain Res; 1992 Nov; 596(1-2):243-50. PubMed ID: 1281744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiographic distribution of brain neurokinin-1/substance P receptors using a highly selective ligand [3H]-[Sar9,Met(O2)11]-substance P.
    Dam TV; Martinelli B; Quirion R
    Brain Res; 1990 Oct; 531(1-2):333-7. PubMed ID: 1705154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
    Gitter BD; Bruns RF; Howbert JJ; Waters DC; Threlkeld PG; Cox LM; Nixon JA; Lobb KL; Mason NR; Stengel PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):737-44. PubMed ID: 7473161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
    Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
    Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.
    Emonds-Alt X; Doutremepuich JD; Heaulme M; Neliat G; Santucci V; Steinberg R; Vilain P; Bichon D; Ducoux JP; Proietto V
    Eur J Pharmacol; 1993 Dec; 250(3):403-13. PubMed ID: 7509286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat.
    Petitet F; Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
    Biochem Biophys Res Commun; 1993 Feb; 191(1):180-7. PubMed ID: 7680554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
    Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
    J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
    Geraghty DP; Mussap CJ; Burcher E
    Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
    Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
    Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and NK1 receptor antagonistic activity of (+/-)-1-acyl-3-(3,4- dichlorophenyl)-3-[2-(spiro-substituted piperidin-1'-yl)ethyl]piperidines.
    Kubota H; Okamoto Y; Fujii M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1541-6. PubMed ID: 9873386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum.
    Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E
    Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors.
    Advenier C; Naline E; Toty L; Bakdach H; Emonds-Alt X; Vilain P; Brelière JC; Le Fur G
    Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1177-81. PubMed ID: 1332556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.
    McLean S; Ganong A; Seymour PA; Bryce DK; Crawford RT; Morrone J; Reynolds LS; Schmidt AW; Zorn S; Watson J; Fossa A; DePasquale M; Rosen T; Nagahisa A; Tsuchiya M; Heym J
    J Pharmacol Exp Ther; 1996 May; 277(2):900-8. PubMed ID: 8627572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists.
    Duffy RA; Varty GB; Morgan CA; Lachowicz JE
    J Pharmacol Exp Ther; 2002 May; 301(2):536-42. PubMed ID: 11961054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two related neurokinin-1 receptor antagonists have overlapping but different binding sites.
    Greenfeder S; Cheewatrakoolpong B; Anthes J; Billah M; Egan RW; Brown JE; Murgolo NJ
    Bioorg Med Chem; 1998 Feb; 6(2):189-94. PubMed ID: 9547942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen challenged guinea-pigs.
    Costello RW; Fryer AD; Belmonte KE; Jacoby DB
    Br J Pharmacol; 1998 May; 124(2):267-76. PubMed ID: 9641542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.